C

Cardinal Health

Distributes medicines and medical supplies

Principal Specialist - Quality Assurance

Full-TimeDeadline 11/3/26
$80.9k - $104k
Mid, Senior
Bachelor's
Indianapolis, IN, USA
In Person
Manufacturing Quality & TestValidation, Compliance & Quality Systems
Company Does Not Provide H1B Sponsorship

About the job

Requirements
  • A bachelor's degree in a related field or equivalent work experience is preferred.
  • An advanced degree may be preferred.
  • Four to eight years of experience in a related field is preferred.
  • Apply comprehensive knowledge and a thorough understanding of concepts, principles, and technical capabilities to perform varied tasks and projects.
  • May contribute to the development of policies and procedures.
  • Work on complex projects of large scope.
  • Develop technical solutions to a wide range of difficult problems that are innovative and consistent with organizational objectives.
  • Complete work independently, receiving general guidance on new projects; work is reviewed for the purpose of meeting objectives.
  • May act as a mentor to less experienced colleagues.
Responsibilities
  • Ensure quality standards and procedures are followed and oversee quality monitoring and assurance to ensure manufactured products meet quality standards.
  • Inspect and sample products throughout the manufacturing process.
  • Establish and maintain quality control procedures.
  • Assist in determining the types of tests to be performed and the documentation and reporting requirements.
  • Interact with manufacturing and service functions to establish quality standards for raw materials, work in process, and finished products.
  • Champion Quality, Good Manufacturing Practices (GMP) compliance, and Environmental, Health, and Safety (EHS)/Radiation Safety practices.
  • Develop and lead Good Manufacturing Practice/Good Documentation Practice (GMP/GDP) training for employees and follow and mentor employees on GDP/GMP requirements.
  • Partner with plant management and personnel to troubleshoot quality deficiencies and implement corrective measures to eliminate quality problems.
  • Assist in releasing final products in compliance with applicable regulations and marketing authorizations.
  • Review and disposition incoming raw materials and components.
  • Ensure quality events are complete and accurate and resolved in a timely manner consistent with applicable quality agreements; approve minor quality events.
  • Network across business and functional units to achieve positive outcomes.
  • Challenge the design, conduct, and reporting of GMP activities, including metrics and annual reporting, using knowledge of the product production process.
  • Understand technical and product-release issues and evaluate their potential impact on product quality and compliance.
  • Provide ideas for continuous improvement of the GMP Quality Management System.
  • Escalate complex issues to management in a timely manner.
  • Prioritize work and ensure it is delivered efficiently.
  • Perform other job duties as assigned.
Desired Qualifications
  • A bachelor's degree in a related field or equivalent work experience.
  • An advanced degree may be preferred.
  • Four to eight years of experience in a related field.

About the company

Cardinal Health distributes pharmaceuticals and medical products to pharmacies, hospitals, clinics and physician offices, mainly in the United States. Its largest business buys branded, generic and specialty medicines from drugmakers and delivers them to retail chains, independent pharmacies and health systems. The company also makes and sources Cardinal Health brand medical and surgical supplies, runs nuclear pharmacies that prepare radioactive drugs for imaging, and ships home-health supplies directly to patients. It earns most of its revenue from the margin on products it distributes, plus manufacturing, logistics and services for specialty physician practices. Cardinal Health was founded in 1971 and is based in Dublin, Ohio.

Company Size

10,001+

Company Stage

N/A

Total Funding

$270.6M

Headquarters

Dublin, California

Founded

1971

Get referred to Cardinal Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Equity has momentum: in August 2026, Cardinal guided fiscal 2027 EPS growth of 13% to 15%, above its long-term target.
  • Specialty drugs drive profit: brand and specialty medicines lifted pharma segment profit 23% in the year ending June 2026.
  • Cardinal keeps raising its payout: in May 2026, its board lifted the quarterly dividend to $0.5158 per share from $0.5107.

What critics are saying

  • One buyer dominates: CVS Health supplied 28% of Cardinal's fiscal 2026 revenue, and the five largest customers 43%.
  • Opioid bills continue: Cardinal held $4.3 billion for national settlements in June 2026 and paid $374 million in July.
  • Factory jobs are going: Cardinal subsidiary KPR filed in March 2026 to close its Augusta, Georgia plant, cutting 213 jobs.

What makes Cardinal Health unique

  • Cardinal owns specialist doctor networks: its management companies support about 3,000 gastroenterology, urology and other providers in 32 states.
  • Cardinal makes products as well as moving them: its own-brand medical and surgical supplies drive growth in its supplies segment.
  • Cardinal runs nuclear pharmacies: its Nuclear and Precision Health unit prepares radioactive drugs used in medical imaging.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Paid Vacation
  • Health Savings Account/Flexible Spending Account
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Short- and Long-term Disability Coverage
  • Paid Parental Leave
  • Wellness Program

Company News

Yahoo Finance
Aug 11th, 2026
Cardinal Health forecasts profit above estimates on specialty drug demand, eyes $1B buyback

Cardinal Health forecast fiscal 2027 profit between $12.40 and $12.60 per share, exceeding analyst expectations of $12.04, driven by strong demand for specialty drugs. The US drug distributor's shares rose over 4% in premarket trading. The company's fourth-quarter adjusted profit of $2.91 per share beat estimates of $2.42. However, total revenue of $63.67 billion missed expectations of $65.03 billion. Cardinal Health is benefiting from rising demand for biosimilars and high-margin medicines treating cancer, rheumatoid arthritis, and autoimmune diseases. Its Pharmaceutical and Specialty Solutions unit saw sales increase 6% to $55.4 billion. Last month, Cardinal purchased AdaptHealth's diabetes business and Strive Medical for approximately $360 million combined. The company also announced $1 billion in planned share repurchases for fiscal 2027.

Healthcare Dive
Jul 21st, 2026
Cardinal Health acquires Strive Medical and AdaptHealth's diabetes unit for $360M to expand home care services

Cardinal Health has agreed to acquire multi-specialty supply company Strive Medical and AdaptHealth's diabetes business for a combined $360 million in cash. The drug distributor said the acquisitions will expand its at-home solutions business, which delivers medical supplies directly to patients. The deals build on Cardinal's recent investments in home care services. The company's at-home unit generated $1.7 billion in revenue during its third quarter this year, helping grow profit by 34% year over year. Cardinal expects the acquisitions to be earnings accretive within a year of closing. AdaptHealth's diabetes unit serves over 225,000 patients annually, primarily delivering continuous glucose monitors. Strive serves more than 20,000 customers yearly, specialising in urology, wound care and incontinence supplies.

PR Newswire
Jan 31st, 2024
Cardinal Health To Acquire Specialty Networks And Its Pps Analytics Platform, A Technology Enabled Multi-Specialty Group Purchasing And Practice Enhancement Organization In Urology, Rheumatology And Gastroenterology

Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices. Transaction creates platform for Cardinal Health expansion across specialty therapeutic areas. Transaction enhances capabilities of Cardinal Health Specialty and supports ongoing build of Navista™ NetworkDUBLIN, Ohio, Jan. 31, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that it has entered into a definitive agreement to acquire Specialty Networks, a technology-enabled multi-specialty group purchasing and practice enhancement organization for $1.2B in cash. Specialty Networks creates clinical and economic value for independent specialty providers and partners across multiple specialty GPOs: UroGPO, Gastrologix and GastroGPO, and United Rheumatology

Intelligence360 News
Mar 7th, 2023
Cardinal Health To Spend $3,100,000.00 To Occupy 3,794 Square Feet Of Space In Indianapolis Indiana.

Cardinal Health to spend $3,100,000.00 to occupy 3,794 square feet of space in Indianapolis Indiana. Cardinal Health to spend $3,100,000.00 to occupy 3,794 square feet of space in Indianapolis Indiana.Indianapolis, Indiana — According to state and local economic development sources, Cardinal Health plans to invest $3,100,000.00 to build out 3,794 square feet of new space in Indianapolis. The company plans to occupy the new space at 7736 Zionsville Rd in Indianapolis, on or about September 1, 2023. According to the company website Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities. With operations in more than 30 countries and approximately 44,000 employees globally, Cardinal Health is essential to care. We are navigating the complexities of healthcare and providing scaled solutions to help our customers thrive in a changing world

GlobeNewswire
Jul 26th, 2022
RxLive Raises $5 Million Series A to Deliver Population Health Telepharmacy Solutions for At-Risk Patients

Digital Health Startup Is Tackling Medication Mismanagement, a $500 Billion Problem...